SOUTH SAN FRANCISCO, Calif., Nov. 3, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report third quarter 2009 results on Monday, November 9th, 2009. A conference call and webcast hosted by OXiGENE management will begin at 9:00 a.m. EST (6:00 a.m. PST).
